Hypertrophic Cardiomyopathy

Maron, Barry J.; Salberg, Lisa

doi:10.1007/978-3-642-68282-7

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2002

2014

Publication Types

Select...

Article4

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 303 publications

References 104 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Hypertrophic Cardiomyopathy

Maron¹

2002

JAMA

1,942

1,380

View full text Add to dashboard Cite

Substantial understanding has evolved regarding the epidemiology and clinical course of HCM, as well as novel treatment strategies that may alter its natural history. An appreciation that HCM, although an important cause of death and disability at all ages, does not invariably convey ominous prognosis and is compatible with normal longevity should dictate a large measure of reassurance for many patients.

show abstract

Hypertrophic Cardiomyopathy

Maron¹

2002

JAMA

1,942

1,380

View full text Add to dashboard Cite

show abstract

Hypertrophic cardiomyopathy in adults: An overview

Jacobs

2014

Journal of the American Association of Nurse Practitioners

View full text Add to dashboard Cite

Purpose To present an overview of clinical issues related to adults with hypertrophic cardiomyopathy (HCM), their presenting symptoms, diagnosis, physical examination findings, treatment, and follow‐up care. Data sources A comprehensive search of Medline (PubMed) and CINAHL was conducted using the key terms HCM, treatment, diagnosis, sudden cardiac death (SCD), and complications. This search yielded 21 articles used for this article. There were three reference books used for background, diagnosis, and treatment information as well. Conclusions Although HCM is the most prevalent genetic disorder affecting the heart, it often goes undiagnosed until midlife after patients show symptoms of myocardial remodeling. Adults with cardiomyopathy suffer SCD or adverse events such as stroke and heart failure from HCM. Early diagnosis will prevent SCD, improve quality of life, and slow patient's progression to heart failure. Implications for practice Early recognition of HCM in adults by their primary care providers will improve patients’ quality of life and reduce incidence of SCD, heart failure, and stroke.

show abstract

Actin-Binding Proteins and Disease

Remedios¹,

Chhabra²

2008

View full text Add to dashboard Cite

Hypertrophic Cardiomyopathy

Cited by 303 publications

References 104 publications

Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy in adults: An overview

Actin-Binding Proteins and Disease

Contact Info

Product

Resources

About